insights_auto
Why is ALMKT down २.२०%?
Dive Deeperchevron_right
ALMKT:EPA
Mauna Kea Technologies SA
€ ०.१४
arrow_downward
-२.२०%(-०.००३२) 1D
सेप्टेम्बर २९, १३:२४:३६ GMT+२ · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALMKT...
Open
€ ०.१४
High
€ ०.१५
Low
€ ०.१४
Mkt. cap
२.७४ करोड
Avg. vol.
५.१४ लाख
Volume
१.७० लाख
P/E ratio
१.१६
52-wk high
€ ०.२३
52-wk low
€ ०.०७
EPS
€ ०.१२
Shares outstanding
१९.५३ करोड
No. of employees
५९
Open
€ ०.१४
High
€ ०.१५
Low
€ ०.१४
Mkt. cap
२.७४ करोड
Avg. vol.
५.१४ लाख
Volume
१.७० लाख
P/E ratio
१.१६
52-wk high
€ ०.२३
52-wk low
€ ०.०७
EPS
€ ०.१२
Shares outstanding
१९.५३ करोड
No. of employees
५९
Profile
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
About Mauna Kea Technologies SA